A Study of a New PET Scanner in People With Cancer
NCT07690917 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2026-07-08
Summary
The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
Conditions
- Non Small Cell Lung Carcinoma NSCLC
- Head and Neck Cancer
- Prostate Cancer
Interventions
- DIAGNOSTIC_TEST
-
Biograph Vision Quadra scanner
new total-body PET scanner, 1 or 2 additional scans with the Biograph Vision Quadra scanner.
- DIAGNOSTIC_TEST
-
PET/CT
Scheduled PET/CT scan
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Heiko Schoder, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2029-06-30
- Completion
- 2029-06-30
Countries
- United States
Study Locations
More Related Trials
-
The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
NCT00598065 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
NCT02810873 ·Status: TERMINATED ·Phase: NA
-
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection
NCT05513027 ·Status: TERMINATED ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors
NCT02526511 ·Status: COMPLETED ·Phase: NA
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
NCT02978586 ·Status: COMPLETED
-
Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images
NCT01109953 ·Status: TERMINATED
-
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
NCT07619599 ·Status: RECRUITING ·Phase: PHASE1
-
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
NCT02084147 ·Status: COMPLETED ·Phase: NA
-
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
NCT04173104 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
NCT07026981 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors
NCT07420036 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT
NCT04685798 ·Status: TERMINATED ·Phase: NA
-
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
NCT04161781 ·Status: COMPLETED
-
Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics
NCT02144311 ·Status: COMPLETED ·Phase: NA
-
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9
NCT05737615 ·Status: WITHDRAWN ·Phase: PHASE1
-
Spectroscopy With Surface Coils and Decoupling
NCT00581815 ·Status: COMPLETED ·Phase: PHASE1
-
PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
NCT03286972 ·Status: TERMINATED
-
68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT06084767 ·Status: RECRUITING ·Phase: NA
-
PET/MR Characterization of Renal Cell Carcinomas
NCT04271254 ·Status: TERMINATED ·Phase: NA
-
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
NCT01892540 ·Status: COMPLETED ·Phase: NA
-
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
NCT07132645 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
68Ga-NYM096 PET/CT in Various Kinds of Cancer
NCT07144748 ·Status: RECRUITING ·Phase: NA